Back to top
more

HEARTWARE INTL (HTWR)

(Delayed Data from NSDQ)

$57.98 USD

57.98
248,829

-0.02 (-0.03%)

Updated Aug 22, 2016 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Brokerage Reports

0 items in cart

[HTWR]

Reports for Purchase

Showing records 1 - 20 ( 94 total )

Industry: Medical - Instruments

Record: 1

05/29/2013

Company Report

Pages: 4

We are dropping coverage due to analyst departure

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 2

03/14/2013

Company Report

Pages: 7

Recent Financing Removes a Soft Overhang and Provides Flexibility for Pipeline Development; Reiterate OP

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 3

03/03/2013

Daily Note

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of March 4

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 4

02/27/2013

Company Report

Pages: 8

Q4:12 Recap; Very Solid Progress with HVAD BTT Launch; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 5

02/24/2013

Daily Note

Pages: 6

Q4:12 Earnings Preview: Focus on Launch Commentary; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 6

02/07/2013

Daily Note

Pages: 4

HVAD Field Correction Notice is not a Material Concern; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 7

01/10/2013

Company Report

Pages: 7

Thoughts on Q4:12 Preannounce Beat; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 8

11/21/2012

Company Report

Pages: 8

HVAD Receives Approval for BTT; Reiterate OUTPERFORM and Raising FV to $105 from $101

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 9

11/20/2012

Company Report

Pages: 9

Receives Approval for BTT; Reiterate OUTPERFORM and Raising FV to $105 from $101

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 10

11/07/2012

Company Report

Pages: 6

Q3:12 Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 11

10/15/2012

Daily Note

Pages: 4

REVIVE-IT Withdrawal Is not a Major Surprise

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 12

10/12/2012

Daily Note

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of October 14

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 13

09/20/2012

Daily Note

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of September 23

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 14

09/06/2012

Daily Note

Pages: 4

Expect Minimal Impact from LVADRelated Presentations at HFSA Conference; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 15

08/10/2012

Industry Report

Pages: 7

Life Sciences MAC Best Ideas Conference

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 16

08/08/2012

Company Report

Pages: 10

HVAD Pulls Further Ahead in Europe; Reiterate OUTPERFORM and Raising FV to $101 from $98

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 17

08/03/2012

Company Report

Pages: 6

Q2:2012 Preview; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: FELT A

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 18

08/02/2012

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of August

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 19

07/27/2012

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of July 29

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 20

07/06/2012

Industry Report

Pages: 5

LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of July 8

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

// eof